Insider Selling: Colgate-Palmolive (NYSE:CL) SVP Sells 10,170 Shares of Stock

Share on StockTwits

Colgate-Palmolive (NYSE:CL) SVP John J. Huston sold 10,170 shares of the company’s stock in a transaction on Monday, August 12th. The stock was sold at an average price of $71.05, for a total value of $722,578.50. Following the sale, the senior vice president now owns 48,965 shares of the company’s stock, valued at $3,478,963.25. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Colgate-Palmolive stock opened at $71.37 on Friday. The company has a current ratio of 1.13, a quick ratio of 0.78 and a debt-to-equity ratio of 32.25. The company has a market capitalization of $61.51 billion, a PE ratio of 25.15, a P/E/G ratio of 4.61 and a beta of 0.76. Colgate-Palmolive has a 12 month low of $57.41 and a 12 month high of $76.41. The stock has a 50-day moving average price of $72.54 and a two-hundred day moving average price of $69.90.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 26th. The company reported $0.72 EPS for the quarter, meeting the consensus estimate of $0.72. The firm had revenue of $3.87 billion during the quarter, compared to the consensus estimate of $3.88 billion. Colgate-Palmolive had a negative return on equity of 10,821.98% and a net margin of 14.77%. The business’s quarterly revenue was down .5% on a year-over-year basis. During the same period last year, the company earned $0.77 earnings per share. As a group, analysts predict that Colgate-Palmolive will post 2.84 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Thursday, July 18th were given a $0.43 dividend. The ex-dividend date was Wednesday, July 17th. This represents a $1.72 annualized dividend and a yield of 2.41%. Colgate-Palmolive’s dividend payout ratio is presently 57.91%.

Several analysts recently weighed in on CL shares. Argus upped their price objective on Colgate-Palmolive from $72.00 to $82.00 and gave the stock a “buy” rating in a research report on Tuesday, June 11th. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $77.00 price objective for the company. in a research report on Friday, June 7th. UBS Group upped their price objective on Colgate-Palmolive from $80.00 to $82.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. Bank of America set a $80.00 price objective on Colgate-Palmolive and gave the stock a “buy” rating in a research report on Friday, July 12th. Finally, Piper Jaffray Companies started coverage on Colgate-Palmolive in a research report on Tuesday. They set an “overweight” rating for the company. One equities research analyst has rated the stock with a sell rating, twelve have issued a hold rating and six have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $73.13.

A number of institutional investors have recently bought and sold shares of the business. Krane Funds Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the second quarter valued at about $25,000. Meridian Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive in the first quarter valued at about $29,000. Lipe & Dalton acquired a new stake in shares of Colgate-Palmolive in the second quarter valued at about $29,000. WP Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the first quarter valued at about $34,000. Finally, Enterprise Trust & Investment Co acquired a new stake in shares of Colgate-Palmolive in the second quarter valued at about $36,000. Hedge funds and other institutional investors own 75.64% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Featured Story: What is Cost of Goods Sold (COGS)?

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Meeder Asset Management Inc. Reduces Position in Capri Holdings Ltd
Meeder Asset Management Inc. Reduces Position in Capri Holdings Ltd
Meeder Asset Management Inc. Buys 435 Shares of Allstate Corp
Meeder Asset Management Inc. Buys 435 Shares of Allstate Corp
Meeder Asset Management Inc. Reduces Stock Holdings in Helmerich & Payne, Inc.
Meeder Asset Management Inc. Reduces Stock Holdings in Helmerich & Payne, Inc.
SBA Communications Co.  Shares Sold by Meeder Asset Management Inc.
SBA Communications Co. Shares Sold by Meeder Asset Management Inc.
Cactus Inc  Position Increased by Meeder Asset Management Inc.
Cactus Inc Position Increased by Meeder Asset Management Inc.
Meeder Asset Management Inc. Purchases 622 Shares of Zions Bancorporation NA
Meeder Asset Management Inc. Purchases 622 Shares of Zions Bancorporation NA


© 2006-2019 Ticker Report